全文获取类型
收费全文 | 12569篇 |
免费 | 1363篇 |
国内免费 | 408篇 |
专业分类
耳鼻咽喉 | 193篇 |
儿科学 | 283篇 |
妇产科学 | 343篇 |
基础医学 | 1591篇 |
口腔科学 | 603篇 |
临床医学 | 1293篇 |
内科学 | 2128篇 |
皮肤病学 | 159篇 |
神经病学 | 828篇 |
特种医学 | 325篇 |
外国民族医学 | 3篇 |
外科学 | 1705篇 |
综合类 | 1073篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 799篇 |
眼科学 | 339篇 |
药学 | 1220篇 |
7篇 | |
中国医学 | 355篇 |
肿瘤学 | 1091篇 |
出版年
2024年 | 22篇 |
2023年 | 157篇 |
2022年 | 336篇 |
2021年 | 511篇 |
2020年 | 362篇 |
2019年 | 478篇 |
2018年 | 497篇 |
2017年 | 417篇 |
2016年 | 398篇 |
2015年 | 604篇 |
2014年 | 735篇 |
2013年 | 748篇 |
2012年 | 928篇 |
2011年 | 972篇 |
2010年 | 723篇 |
2009年 | 552篇 |
2008年 | 734篇 |
2007年 | 705篇 |
2006年 | 671篇 |
2005年 | 592篇 |
2004年 | 517篇 |
2003年 | 421篇 |
2002年 | 365篇 |
2001年 | 237篇 |
2000年 | 215篇 |
1999年 | 199篇 |
1998年 | 123篇 |
1997年 | 126篇 |
1996年 | 102篇 |
1995年 | 68篇 |
1994年 | 79篇 |
1993年 | 77篇 |
1992年 | 86篇 |
1991年 | 94篇 |
1990年 | 88篇 |
1989年 | 77篇 |
1988年 | 60篇 |
1987年 | 50篇 |
1986年 | 39篇 |
1985年 | 25篇 |
1984年 | 24篇 |
1983年 | 16篇 |
1982年 | 9篇 |
1981年 | 13篇 |
1980年 | 14篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1977年 | 13篇 |
1975年 | 6篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
复方磺胺嘧啶锌涂膜剂治疗烧伤的疗效观察 总被引:6,自引:1,他引:5
目的 观察复方磺胺嘧啶锌涂膜剂治疗浅Ⅱ度、深Ⅱ度 烧伤创面、残余创面抗感染和促进创面愈合的作用。方法 治疗组清 创 后应用复方磺胺嘧啶锌涂膜剂涂于创面的表面,对照组应用1%磺胺嘧啶银霜覆盖创面,共治 疗119例烧伤患者(即222个创面),包括浅Ⅱ度烧伤、深Ⅱ度烧伤、残余小创面及供皮区创面 ,并观察创面完全愈合时间、创面表面细菌培养用药前与用药中的情况以及复方磺胺嘧啶锌 涂膜剂对全身情况的影响。结果 浅Ⅱ度烧伤创面治疗组(10.25±1 .6 9)天完全愈合,对照组(13.15±2.03)天愈合;深Ⅱ度创面治疗组(18.10±2.72)天愈合 ,对照组(21.2±3.64)天愈合,治疗组明显优于对照组(P<0.05);治疗组用药前细 菌培养阳性率是38.8%,治疗中降至9.0%;对照组用药前细菌培养阳性率为32.7%,治疗 中降至25.4%;两组间比较具有显著性差异(P<0.05);患者未出现疼痛、过敏反应 和其它不良反应。结论 复方磺胺嘧啶锌涂膜剂治疗烧伤创面可促进上 皮 化、加速创面愈合、有效地防治创面感染,该药应用简便、适用于社区、基层常见的中、小 面积浅度烧伤治疗。 相似文献
52.
Xu Li Siming Li Zhihong Chi Chuanliang Cui Lu Si Xieqiao Yan Lili Mao Bin Lian Bixia Tang Xuan Wang Xue Bai Li Zhou Yan Kong Jie Dai Jun Guo Xinan Sheng 《Urologic oncology》2021,39(1):75.e1-75.e8
PurposeTo investigate the clinical characteristics, chemosensitivity, and outcome of metastatic upper tract urothelial carcinoma (UTUC).Patients and MethodsRecords of patients with metastatic UTUC since January 2005 were retrieved from a database that included clinical and survival data. Statistical analyses including survival and multivariate analyses of factors were respectively performed by the Kaplan-Meier method and Cox proportional hazard model.ResultsA total of 250 consecutive UTUC cases were evaluated. There were 56 patients (22.4%) with initially diagnosed stage IV disease. The most common metastatic sites were lung (39.6%), distant lymph nodes (39.2%), bone (19.6%), liver (18.0%), and adrenal gland (7.2%), respectively, and the local recurrence rate was 10.4%. Two hundred thirteen patients received first-line chemotherapy. The overall response rate was only 28.7% and the median progression-free survival time was only 5.0 months. The overall survival time of the cohort was 18.0 months. Multivariate analyses showed that initially diagnosed stage IV disease, number of metastatic organs ≥3, no response to chemotherapy and cycles of chemotherapy ≤2 were adverse prognosticators for overall survival.ConclusionUTUC presented to be more prone to metastasize than locally recur and thought to have low chemosensitivity. Stage IV disease at initial diagnosis, number of metastatic organs, response and cycles of chemotherapy were independent prognosticators for metastatic UTUC. 相似文献
53.
JS Tsang Chi Chung Foo Jeremy Yip Hok Kwok Choi Wai Lun Law Oswens Siu Hung Lo 《The surgeon》2021,19(3):150-155
IntroductionThe difference in outcome between right (RCD) and left colonic diverticulitis (LCD) is not well established. The aim of this study was to analyse the presentation and surgical outcome of RCD versus left-sided disease following emergency surgery.MethodWe conducted a retrospective review of patients presenting with acute diverticulitis over a 10-year period from 2004 to 2014 to a tertiary unit. Patient demographics, Hinchey classification, need for emergency surgery, perioperative outcome and recurrence were evaluated.ResultsIn total 360 patients presented with acute diverticulitis, 218 (61%) were right-sided and 142 (39%) were left-sided. The mean age (57 yrs vs 68 yrs) and median length of stay (4 days vs 5 days) were significantly less in RCD (p < 0.001). The need for emergency surgery was similar between RCD and LCD (30.7% vs 23.2%, p = 0.12). Sixty-seven (31%) patients with RCD required emergency surgery, 42 (62.7%) of these were based on a presumptive diagnosis of appendicitis and underwent laparoscopic appendicectomy only. Operative morbidity (10.4% vs 51.5%, p < 0.001) and mortality were significantly higher in LCD (1.5% v 15.2%, p = 0.007). Subgroup analysis of non-appendicectomy, RCD patients, showed LCD were more likely to require surgery (11.5% vs 23.2%, p = 0.003). There was no difference in recurrence (p = 0.6).ConclusionRight colonic diverticulitis patients are younger and disease course is more benign compared to LCD. Presentation can be confused with appendicitis without proper imaging. In the rare cases where emergency surgery is required, RCD is associated with a lower operative morbidity and mortality compared to left-sided disease. 相似文献
54.
Jiang Bian Ting Wang Jijun Sun Xiaozhen He Zhijiao Wu Songmei Zhang Hao Chi Tingting Fan Shaowen Wang Weiyun Shi Qingguo Ruan 《American journal of transplantation》2021,21(12):3858-3870
The relevance of Tregs in the induction of tolerance against corneal allografts has been well established. Although it is well known that the conversion of Tregs into effector-like cells contributes to the loss of corneal immune privilege, the underlying mechanism is still not fully understood. Using heterologous penetrating keratoplasty model, we found that Tregs from corneal allograft rejected mice (inflam-Tregs) exhibit impaired function and characteristics of effector T cells. Further study showed that the expression of NF-κB c-Rel, a key mediator of effector T cell function, was significantly increased in inflam-Tregs. Mechanistic study revealed that elevated NF-κB c-Rel level in inflam-Tregs impaired Treg function through the promotion of inflammatory cytokine production and glycolysis. More importantly, we demonstrated that targeting NF-κB c-Rel was able to improve the immune suppressive function of inflam-Tregs in vitro and enhance the potential of them to suppress corneal transplantation rejection. Therefore, our current study identified NF-κB c-Rel as a key mediator of the conversion of Tregs into effector-like cells when under inflammatory environment. 相似文献
55.
56.
57.
Existing criteria for admission of newborns to the special care nursery, Sarawak General Hospital, resulted in the admission of many neonates with certain risk factors ("at risk" neonates). To test whether such babies could be safely and better cared for in postnatal wards, 392 of these babies were randomly allocated into two groups. One group of 196 was admitted to the special care nursery and the other group of 196 was cared for with their mothers in the postnatal wards. The two groups were compared for mortality, morbidity and breastfeeding. There was no significant difference in mortality and morbidity between the two groups. While in hospital a larger proportion of babies cared for in postnatal wards were breastfed, compared to babies admitted to the special care nursery. In addition, they initiated their breastfeeding earlier. Babies with these risk factors should therefore be cared for with their mothers in the postnatal wards. 相似文献
58.
Recombinant human epidermal growth factor (rhEGF), a polypeptide of 53 amino acid residues, is subject to degradation by numerous
enzymes, especially proteases, when it is applied on the skin for the treatment of open wound. Amastatin, aprotinin, bestatin,
EDTA, EGTA, gabexate, gentamicin, leupeptin, and TPCK were investigated for the possible protease inhibitors, which may use
to protect rhEGF from degradation by the enzymes in the skin. Skin homogenates containing protease inhibitors and rhEGF were
incubated at 37°C for 30 minutes. After the reaction was stopped with trifluoroacetic acid, the amount of rhEGF remaining
in the sample was determined with an HPLC method. The percentages of rhEGF degraded, at the skin/PBS ratio of 0.25, in the
mouse, rat, and human skin homogenate were 85%, 70%, and 46%, respectively. The degree of degradation of rhEGF in the cytosolic
fraction was higher than that in the membrane fraction and these enzyme reactions were completed in 30 minutes. Bestatin,
EGTA, and TPCK showed significant inhibitory effects on the degradation of rhEGF in the two fractions (p<0.05), while the
other protease inhibitors had no significant inhibitory effects or, even resulted in deleterious effects. Therefore, the formulation
containing one or several inhibitors among these effective inhibitors would be a promising topical preparation of rhEGF for
the treatment of open wound. 相似文献
59.
环枕关节脱位:附二例报告 总被引:1,自引:0,他引:1
环枕脱位十分少见。此种病例,由于环枕部结构复杂,照片显示常不够清楚。人们往往只注住只注意环枢椎的关系而对环枕脱位的警惕性不足,容易漏诊,其后果是严重的。本文报道两例环枕关节脱位病例,并对该病的病因、发病机制、局部解剖、合并症及其诊断要点进行分析,并提出“斜坡-齿突线”对本病的诊断有重要意义。 相似文献
60.
Shang-Ying P. King Allison M. Agra Huey-Shin L. Shen Cecilia L. Chi David B. Adams Violante E. Currie Joseph R. Bertino Henry J. Pieniaszek Jr. Check Y. Quon 《Cancer chemotherapy and pharmacology》1994,35(2):101-108
The protein binding of weakly acidic and basic drugs has been shown to be altered in cancer patients. Brequinar is a weakly acidic, low-clearance, and highly protein-bound (>98% bound) antitumor agent. The pharmacokinetic parameters of brequinar are subject to large interpatient variability. This large interpatient variability may be related to brequinar's plasma protein-binding capacity (assuming no change in the intrinsic clearance of the unbound drug). The objectives of this study, therefore, were (a) to characterize brequinar's protein binding in the plasma of healthy donors and cancer patients and (b) to examine the relationships between brequinar's plasma protein binding and its pharmacokinetics in patients. Brequinar protein binding was determined in human serum albumin (HSA) solution, drug-free donor plasma, and brequinar-free, predose plasma samples obtained from a phase I cancer trial. Pharmacokinetic results from this study were used to examine relationships between plasma protein binding and drug disposition. In HSA solution and healthy donor plasma, brequinar's protein binding as determined using spiked samples was concentration-dependent. The unbound brequinar fraction increased by a factor of 3 (from 0.3% to 0.9% free) in 4% HSA solution and by a factor of 4 (from 0.4% to 1.6% free) in donor plasma as the brequinar concentrations increased from 0.1 to 2.3 mM in the HSA solution and from 0.076 to 1.5 mM in the donor plasma. Analysis of brequinar binding characteristics using the binding ratio and Rosenthal binding plots showed that albumin was the primary protein for brequinar binding in human plasma. The addition of various concentrations of 1-acid glycoprotein to 4% HSA solution did not affect the protein binding of brequinar to HSA. The protein binding determined in the plasma of cancer patients was not quantitatively different, except for variability, from that observed in the plasma of healthy donors. Examination of relationships between the unbound brequinar fraction and pharmacokinetics suggested that plasma protein binding was not a major determinant of brequinar disposition in cancer patients. 相似文献